Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ABBV
#22
AbbVie Inc. Common Stock
260.0
1
USD
+0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.40%
Monthly Change
+2.96%
6 month change
+11.61%
Year Change
+22.45%
Previous Close
256.4
2
Open
260.1
2
Low
259.0
6
High
260.1
3
Volume
1 257
Markets
US Stock Market
Healthcare
Drug Manufacturers—General
ABBV
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Documents
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Q2, 26
Current
Key stats
Total common shares outstanding
1.77 B
1.77 B
1.77 B
1.77 B
1.77 B
1.77 B
1.77 B
Valuation ratios
Enterprise value
364.96 B
321.49 B
403.63 B
398.82 B
374.91 B
438.16 B
450.38 B
Price to earnings ratio
89.16
88.39
175.41
96.82
107.14
71.08
73.04
Price to sales ratio
6.47
5.64
6.88
6.62
6.14
6.93
7.12
Price to cash flow ratio
22.64
17.06
19.67
21.29
18.16
22.87
23.49
Price to book ratio
21.15
30.02
54.21
-123.89
-30.25
-24.11
-24.77
Enterprise value to EBITDA ratio
15.13
12.85
17.48
17.18
12.92
14.43
14.83
Profitability ratios
Return on assets %
0.01
0.01
0
0.01
0.01
0.03
0.03
Return on equity %
0.88
-6.8
-0.07
-0.56
-0.11
-0.61
-0.61
Return on invested capital %
10.07
10.27
1.8
11.01
9.53
19.68
19.68
Gross margin %
70.01
71.82
66.38
72.61
71.88
74.74
74.74
Operating margin %
27.98
31.73
12.07
27.34
26.6
37.86
37.86
EBITDA margin %
43.26
45.26
25.33
72.96
39.5
49.01
49.01
Net margin %
9.64
6.08
1.18
10.93
4.63
21.27
21.27
Liquidity ratios
Quick ratio
0.64
0.61
0.6
0.56
0.68
0.69
0.69
Current ratio
0.76
0.74
0.72
0.67
0.8
0.81
0.81
Inventory turnover
0.92
0.88
1.07
0.92
0.84
0.84
0.84
Asset turnover
0.1
0.11
0.12
0.12
0.11
0.13
0.13
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
0.48
—
—
—
Long term debt to total equity ratio
—
—
—
-19.73
—
—
—
Per share metrics
Operating cash flow per share
0.92
2.91
3.96
2.94
2.16
1.94
11.01
EBIT per share
2.11
2.76
1.07
2.56
2.25
3.63
9.52
EBITDA per share
3.26
3.94
2.26
6.84
3.34
4.7
17.13
Total debt per share
—
—
—
—
—
—
—
Cash per share
2.92
3.65
3.2
2.97
5.29
3.71
3.71
Net current asset value per share
15.62
16.52
16.11
16.39
18.9
19.01
19.01
Tangible book value per share
0.8
-0.1
-1.49
-1.84
-3.75
-3.35
-3.35
Working capital per share
-4.93
-5.93
-6.12
-8.02
-4.83
-4.5
-4.5
Book value per share
0.8
-0.1
-1.49
-1.84
-3.75
-3.35
-3.35
News
JNJ Replaced $913 Million In Lost Sales With $2.4B In New Ones - But Kept Less Than Half
GSK Stock Down 14% in Six Months: Time to Buy, Hold or Exit?
Trump Admin To Target Biotechs With Curbs On Drug Pricing? What Investors Should Know
Aging Population Drives Healthcare Growth: Stocks to Watch
How Is AbbVie’s Stock Performance Compared to Other Healthcare Stocks
AbbVie Seeks EU Nod for Subcutaneous Skyrizi in Crohn's Disease
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
TG Therapeutics: Briumvi's Peak May Be Far Away (Rating Upgrade) (NASDAQ:TGTX)
How Did ABBV's Oncology Sales Hold Up in Q2 Amid Imbruvica Headwinds?
LLY vs. ABBV: Which Stock Has the Stronger Growth Prospects?
RGNX Stock Slumps 25% on FDA Clinical Hold for RGX-121 Gene Therapy
AbbVie Still Has Room To Run (NYSE:ABBV)